Global Cell-based Assays Market Report and Forecast 2024-2032

Global Cell-Based Assays Market Size

The global cell-based assays market was valued at USD 8,677.43 million in 2023, driven by the increasing incidence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 14% during the forecast period of 2024-2032, with the values likely to reach USD 28,220.80 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Cell-Based Assays Market Outlook

• The demand for cell-based assay is increasing, owing to the innovations in cell-based assay technologies, such as high-throughput screening (HTS) and 3D cell culture systems.

• One of the major market trends is the increasing investments in drug discovery and development by pharmaceutical and biotechnology companies, thereby, boosting the demand for cell-based assays.

• The cytotoxicity assay segment is experiencing significant growth driven by the shift towards personalized medicine, which requires precise and targeted therapies.

Global Cell-Based Assays Market Overview

Cell-based assays are laboratory procedures used to measure the biological activity of substances on living cells. These assays evaluate various cellular functions, including cell proliferation, cytotoxicity, cell signaling, and gene expression, to understand the effects of drugs, chemicals, or other biological agents on cell behavior. The cell-based assays are essential tools in modern biomedical research, offering critical insights into cellular functions and the potential effects of therapeutic interventions.

The market is witnessing growth in investment for drug discovery and development by pharmaceutical and biotechnology companies. This is boosting the demand for cell-based assays. This trend is expected to continue, owing to the increasing viability of this approach, the convenience it provides, and the growing number of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Rising incidence of such conditions is driving the need for new and effective therapies, thereby propelling the demand for cell-based assays.

Global Cell-Based Assays Market Growth Drivers

Rising Technological Advancements is Augmenting Market Growth

Recent advancements in technology are a significant driver of the cell-based assays market. Technological advancements in cell-based assay technologies, such as high-throughput screening (HTS) and 3D cell culture systems, have significantly improved the efficiency and accuracy of these assays. For instance, a leading biotech firm named InSphero launched a revolutionary 3D cell culture platform in July 2020. This technology provided more physiologically relevant data, thereby, enhancing the accuracy of drug screening processes and enabling more precise modeling of disease conditions. The adoption of such cutting-edge technologies is expected to significantly boost the market growth.

Rising Focus on Personalized Medicine

The growing emphasis on personalized medicine is another key driver of the cell-based assays market. Personalized medicine requires the development of therapies tailored to individual patient profiles, which often involves extensive use of cell-based assays to understand patient-specific cellular responses to various treatments. For instance, in April 2024, Roche has significantly increased its investment in personalized medicine research, leveraging cell-based assays to develop more precise and effective therapies. This initiative aims to enhance patient outcomes by using cell-based assays to identify the most suitable treatment options based on individual cellular responses, thereby driving the demand for these assays in the market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Cell-Based Assays Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Global Cell-Based Assays Market Segmentation

Market Breakup by Product and Services

• Products
  • Instruments
  • Software
  • Consumables
    • Microplates
    • Probes & Labels
    • Assay Kits
    • Cell Lines
    • Reagents
    • Others

• Services

Market Breakup by Application

• Drug Discovery

• Basic Research

• Predictive Technology

• ADME Studies

• Others

Market Breakup by Assay Type

• Cell Viability Assay

• Cytotoxicity Assay

• Cell Death Assay

• Cell Proliferation Assay

• Others

Market Breakup by End User
 

• Pharmaceutical and Biotechnology Companies

• Academic and Government Research Institutes

• Contract Research Organizations (CROs)

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Cell-Based Assays Market Share

Market Segmentation Based on Product and Services is Anticipated to Witness Substantial Growth

Based on products, the market report offers an insight into instruments, software, and consumables. Since cell-based assays are increasingly used in the healthcare sector for patient diagnosis and drug development activities, the instrument segment is experiencing significant growth. It can be attributed to its efficacy in toxicology studies for safety assessment of drugs and chemicals, further contributing to market expansion. The use of cell-based assays in these activities helps in understanding the cellular responses to new compounds, identifying target interactions, and optimizing lead compounds, ultimately accelerating the drug development timeline. Along with products, services also hold a notable market share. The market has been witnessing a trend of outsourcing services to leverage expertise at a reasonable price.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Cell-Based Assays Market Analysis by Region

Based on the region, the market covers North America, Europe, Asia Pacific, Latin America, as well as the Middle East and Africa. North America is dominating the market share due to rising burden of chronic diseases in the aging population, as well as the presence of an advanced healthcare infrastructure. Further, the increasing technological advancements in cell-based assays, heightened awareness surrounding better diagnostic procedures, and the surge in the adoption of cell-based assay for better results are some of the factors supporting the market growth.

Europe also holds a notable cell-based assays market share driven by increasing investments in healthcare technologies and greater access to advanced medical devices. Additionally, Asia Pacific is expected to witness substantial market growth fueled by the growing patient pool and the rising recognition of cell-based assay benefits. Increased government initiatives to improve healthcare services and the rising disposable income is poised to boost the region’s market share.

Leading Players in the Global Cell-Based Assays Market

The key features of the market report include patents analysis and strategic initiatives which constitutes funding and investment analysis, partnerships, and collaborations analysis by the key players. The major companies in the market are as follows:

Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a leading science and technology company operating in the healthcare, life sciences, and performance materials sectors. Merck KGaA is actively involved in the cell-based assays market. The company's life sciences division, through its brands such as Sigma-Aldrich and Millipore, offers advanced cell-based assay technologies, including high-throughput screening platforms, 3D cell culture systems, and specialized reagents.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, USA, operates in various sectors, including life sciences, analytical instruments, specialty diagnostics, and laboratory products and services. It has wide range of cell-based assays in the market, offering a comprehensive portfolio of products and solutions designed to meet the needs of researchers and clinicians. The company provides advanced cell-based assay technologies, including high-throughput screening (HTS) systems, reagents, assay kits, and cell culture products.

Other key players in the market include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Lonza Group Ltd., PerkinElmer, Inc., Promega Corporation, Charles River Laboratories International, Inc., Eurofins DiscoverX, and Cell Biolabs, Inc., among others.

Key Highlights of the Report

Key Questions Answered in the Global Cell-Based Assays Market Report

• What was the global cell-based assays market value in 2023?
• What is the global cell-based assays market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is market segmentation based on application?
• What is the market segmentation based on products and services?
• What are the major end users in the market?
• What is the market segmentation based on assay types?
• What are the major factors aiding the global cell-based assays market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the major market trends influencing the market? 
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is estimated to witness expedited growth during the forecast period? 
• How does the rise in the chronic diseases impacting the market size?
• How do the technological innovations in cell-based assay affect the market landscape?
• Which application area is expected to have a high market value in the coming years?
• Who are the key players involved in the cell-based assays market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?